Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators

Article abstract of DOI:10.1016/j.bmcl.2018.12.030

Proteasome-mediated degradation of proteins is a vital cellular process and is performed by the ubiquitin-dependent proteasome system (UPS) and the ubiquitin-independent proteasome system (UIPS). While both systems are necessary to maintain healthy cell function, many disease states are characterized by reduced activity of the UPS, and the UIPS cannot by itself maintain proper protein levels. It has been suggested that the 20S core particle (20S CP), the isoform of the proteasome in the UIPS that can degrade proteins without a ubiquitin tag, can be stimulated with a small molecule to assist the 20S CP to accept and hydrolyze substrates more rapidly. Several small molecule stimulators of the 20S CP have since been discovered, including AM-404, an arachidonic acid derivative. AM-404 has previously been shown to inhibit fatty acid amide hydrolase activity. We wished to evaluate what structural components of AM-404 are required to stimulate the 20S CP with the long-term goal of using this information to design a stimulator with better drug-like qualities. We synthesized numerous derivatives of AM-404, varying the chain length, substitutions, and degree of unsaturation. Through this endeavor, we obtained several molecules capable of stimulating the 20S CP to various degrees. We discovered that though chain length is important, the presence of a cis-alkene in a specific location in the aliphatic chain has the greatest impact on the ability to stimulate the 20S CP. Two of the derivatives maintain modest stimulatory activity, and have improved toxicity over AM-404.

Full text of DOI:10.1016/j.bmcl.2018.12.030

Bioorganic&MedicinalChemistryLettersxxx(xxxx)xxx–xxx
Contents lists available at ScienceDirect
Bioorganic & Medicinal Chemistry Letters
journal homepage: www.elsevier.com/locate/bmcl
Analysis of chain length, substitution patterns, and unsaturation of AM-404
derivatives as 20S proteasome stimulators
Rachel A. Colemana, Christine S. Mulia, Yizhou Zhaob, Atul Bhardwaja, Timothy R. Newhouseb,
⁎
Darci J. Tradera,
a Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 W. Stadium Ave, West Lafayette, IN 47907, United States
b Department of Chemistry, Yale University, 225 Prospect Street, New Haven, CT 06520-8107, United States
A R T I C L E I N F O
A B S T R A C T
Keywords:
Proteasome
Synthesis
Stimulator
AM-404
Proteasome-mediated degradation of proteins is a vital cellular process and is performed by the ubiquitin-de-
pendent proteasome system (UPS) and the ubiquitin-independent proteasome system (UIPS). While both systems
are necessary to maintain healthy cell function, many disease states are characterized by reduced activity of the
UPS, and the UIPS cannot by itself maintain proper protein levels. It has been suggested that the 20S core particle
(20S CP), the isoform of the proteasome in the UIPS that can degrade proteins without a ubiquitin tag, can be
stimulated with a small molecule to assist the 20S CP to accept and hydrolyze substrates more rapidly. Several
small molecule stimulators of the 20S CP have since been discovered, including AM-404, an arachidonic acid
derivative. AM-404 has previously been shown to inhibit fatty acid amide hydrolase activity. We wished to
evaluate what structural components of AM-404 are required to stimulate the 20S CP with the long-term goal of
using this information to design a stimulator with better drug-like qualities. We synthesized numerous deriva-
tives of AM-404, varying the chain length, substitutions, and degree of unsaturation. Through this endeavor, we
obtained several molecules capable of stimulating the 20S CP to various degrees. We discovered that though
chain length is important, the presence of a cis-alkene in a specific location in the aliphatic chain has the greatest
impact on the ability to stimulate the 20S CP. Two of the derivatives maintain modest stimulatory activity, and
have improved toxicity over AM-404.
The proteasome is a large protein complex capable of degrading
proteins that a cell no longer requires or that have become damaged.1
There are two established mechanisms by which the proteasome can
recognize and degrade proteins.2 The first is through the ubiquitin-
dependent pathway, commonly abbreviated as UPS. In this pathway, a
protein is tagged with a chain of ubiquitin moieties, which the 19S
regulatory particle (19S RP) can recognize. The 19S RP caps one or both
of the ends of the core particle of the proteasome, called the 20S CP,
Fig. 1A.3 After the 19S RP interacts with the 20S CP, the gate of the 20S
CP is opened and can accept unfolded or disordered proteins. The 19S
RP is also responsible for removing the ubiquitin chain from the protein
substrate and denaturing the protein through an ATP-dependent me-
chanism so it can fit inside the catalytic chamber of the 20S CP to be
hydrolyzed.
substantial amount of 20S CP is present in healthy cells, uncapped to
rapidly degrade misfolded proteins as they are synthesized by the ri-
bosome. The balance of the UPS and the UIPS maintains healthy protein
levels in cells.4
During the normal aging process, the expression levels of the 19S RP
subunits diminishes, which leads to a decrease in the ability of the UPS
to process proteins.5–8 This leaves the UIPS as the major proteasome
pathway to degrade proteins. The UIPS alone cannot regulate the
amount of protein in a cell effectively. This then leads to an accumu-
lation of unwanted proteins in a cell, increased cellular stress, and
eventually apoptosis. A number of diseases, including Parkinson’s and
Alzheimer’s, are associated with the accumulation of toxic proteins and
have an impaired UPS.
It has previously been shown that small molecules can help to sti-
mulate the UIPS by interacting with the 20S CP. This can be done
through two mechanisms of action. The first is through an interaction
with one of the active sites to help the 20S CP turn over a protein
substrate faster. The second is through a gate-opening mechanism,
The 20S CP alone can degrade proteins without the 19S RP and does
so through a ubiquitin-independent proteasome system, or the UIPS.2
Only proteins that have a large region of disorder can fit past the closed-
gate conformation to reach the catalytic core for hydrolysis.
A
⁎ Corresponding author.
E-mail address: dtrader@purdue.edu (D.J. Trader).
https://doi.org/10.1016/j.bmcl.2018.12.030
Received 30 October 2018; Received in revised form 10 December 2018; Accepted 13 December 2018
0960-894X/©2018PublishedbyElsevierLtd.
Pleasecitethisarticleas:Coleman,R.A.,Bioorganic&MedicinalChemistryLetters,https://doi.org/10.1016/j.bmcl.2018.12.030

R.A. Coleman et al.
Bioorganic&MedicinalChemistryLettersxxx(xxxx)xxx–xxx
Table 1
H O
O
Molecules with the same head group as AM-404 but with saturated carbon tails
ranging from three to ten carbons are not effective 20S CP stimulators.
N
H
Molecule
Structure
Stimulation
1
0%
2
3
4
5
6
14%
9%
8%
7%
0%
H
CO O H
S
H
H O
C l
N
SO 3
No 20S CP
Basal Level
GFP-α-synuclein fusion assay in HEK-293T cells.12 Since the scaffold of
AM-404 is already known to penetrate the blood-brain barrier, we
decided to try and retain the aminophenol head group and modify the
length of the aliphatic chain. We recently have developed an effective
assay specifically designed to monitor the stimulation abilities of a
small molecule on the 20S CP. Briefly, this assay is performed in a 96-
or 384-well plate with purified human 20S CP and a reporter peptide
that is 11 amino acids in length with a fluorescence resonance energy
transfer (FRET) pair, Fig. 1C.9 The 20S CP can slowly degrade the FRET
peptide without any stimulation, but upon adding a small molecule
stimulator, the rate of hydrolysis increases substantially. The rate of
hydrolysis of the FRET peptide is then calculated, with and without a
stimulator, to generate a percent increase in hydrolysis over basal level.
This assay was used to test all newly synthesized derivatives.
384-well plate
Stimulator
Time (min)
FRET donor
moiety
FRET acceptor
moiety
FRET peptide
20S CP
Fig. 1. (A) The 20S CP is composed of two alpha rings (purple) and two beta
rings (blue). The N-termini of the alpha ring protein’s form a “gate,” limiting
the amount of protein that can enter the core particle to be hydrolyzed. (B)
Previously discovered small molecules that are believed to interact with the
alpha ring proteins to open the gate, allowing more substrates to enter to be
hydrolyzed. (C) 20S CP activity is monitored using a peptide that upon being
hydrolyzed by the 20S CP generates a fluorescent signal. The increase in sti-
mulation is determined by comparing the rate of hydrolysis of the basal level of
activity to that when a stimulator is added.
Our initial set of studies tested AM-404-like molecules that retained
the aminophenol head group of AM-404 but contained aliphatic tails
ranging from two to nine carbons in length. Based on the results from
molecules 1–6, the aminophenol head group with a saturated chain
cannot stimulate the 20S CP, Table 1. Ortho-substituted and biphenyl
derivatives with a range of aliphatic tail lengths also showed no sti-
mulation, Supporting Information Tables S1 and S2. Neither of these
results is surprising since AM-404 has four cis-double bonds, which can
induce significant structure beyond what can be obtained with a satu-
rated aliphatic tail. An additional set of molecules was synthesized and
tested where the long aliphatic tail was exchanged with moieties that
have substitution, Table 2. We hypothesized that these molecules could
potentially fill the same binding pocket as AM-404. Again, none of these
molecules, with the exception of molecule 9 showed any significant
stimulation (> 20%) over basal level. This was a surprising result as we
had hypothesized that adding more steric bulk on the aliphatic chain
would increase the binding contacts with the 20S CP, eliciting a sti-
mulation result. We hypothesized that even though this series of mo-
lecules had more bulk on the aliphatic chain, as compared to the series
in Table 1, they probably do not reach as far into the same binding
pocket that AM-404 occupies.
where a small molecule disrupts the protein-protein interactions of the
N-termini of the alpha-subunits to allow larger or more substrates to
enter at a faster rate.
A number of gate-opening 20S CP stimulators have been reported,
Fig. 1B.9–12 Many of these stimulators are molecules with long hydro-
phobic tails. For example, sodium dodecyl sulfate (SDS) is known to be
a 20S CP gate opener.13 While SDS can serve as a positive control in a
biochemical assay with purified 20S CP, dosing cells would not work.
Another molecule recently described as a 20S CP stimulator, called AM-
404, can aid SH-SY5Y cells to degrade α-synuclein at 32 µM.12 AM-404
is another molecule with a polar head group and a long aliphatic tail,
but its tail is unsaturated, providing some secondary structure to the tail
portion. AM-404 has been described as an inhibitor of the en-
docannabinoid transport pathway affecting neuropathic pain, and its
metabolite has been shown to disrupt prostaglandin biosynthesis.14,15
We wished to investigate if molecules with shorter aliphatic tails or
with different substitution patterns from that of AM-404 could act as
20S CP stimulators. Here, we report a series of molecules that contain
the aminophenol head group linked to aliphatic chains of varying
length and unsaturation and their effect on the activity of the 20S CP.
Our results indicate that it is not the chain length that is the most im-
portant structural component but a cis-double bond in the carbon chain
that leads to effective 20S CP stimulation.
Based on these results, we decided that molecules with aliphatic
chains substantially longer than the ones we had previously tested
would be needed and that alkenes should be included in the aliphatic
chain to mimic the structure of AM-404. AM-404 is derived by com-
bining arachidonic acid with aminophenol, but arachidonic acid is not
very stable as it has been shown to oxidize readily.16 We tested other
naturally occurring acids such as docosahexaenoic acid (DHA) and oleic
AM-404 was initially discovered as a 20S CP stimulator through a
mass spectrometry-based screening technique and then verified using a
2

R.A. Coleman et al.
Bioorganic&MedicinalChemistryLettersxxx(xxxx)xxx–xxx
Table 2
Table 4
Adding steric bulk to the aliphatic side chain off the AM-404 head group does
not induce any simulation of the 20S CP.
After appending the phenolic amide, the best stimulators still required the cis-
alkene at carbon nine.
Molecule
Structure
Stimulation
Molecule
Structure
Stimulation
201%
7
0%
16
8
9
7%
17
18
19
85%
60%
260%
20%
10
0%
11
12
9%
3%
20
63%
Oleic acid and four other acids that showed the ability to stimulate
the 20S CP were converted to the phenolic amide derivatives, molecules
16–20, and were tested for their ability to stimulate purified 20S CP,
Table 4. The oleic acid derivative, 16, stimulated the 20S CP 201% over
basal level. Molecules 17 and 18, which do not have the cis-alkene at
position nine to ten, showed substantially less ability to stimulate the
20S CP. Molecule 19, which has an extra trans-alkene alpha to carbonyl,
was the best derivative, stimulating the hydrolysis activity of the 20S
CP by 260%. Molecule 20 has two trans alkenes, and again, is not a very
effective 20S CP stimulator. These results highlight that a cis-alkene is
required to be an effective stimulator. Molecules 16 and 19 are possibly
not as effective as AM-404 because their alkene is between other cis-
alkenes or because the additional cis-alkenes of AM-404 may induce
additional contacts with the 20S CP. Three derivatives of molecule 16
were synthesized by changing the phenolic amide to other substituted
aryl groups and were found to have a greatly diminished capacity to
stimulate the 20S CP, Supporting Information Table S5. The combina-
tion of all these results highlight that the phenolic amide and at least
one cis-alkene in the aliphatic tail are required for the molecule to be
able to stimulate the 20S CP.
acid, which are known to be more stable in aqueous solutions, for their
ability to stimulate the 20S CP. Both DHA and oleic acid substantially
increased the hydrolysis activity of the 20S CP, Supporting Information
Table S3. With these results in hand and with the development of recent
allyl-palladium catalyzed carboxylic acid α,β-dehydrogenation reac-
tions, we generated a series of unnatural fatty acids.17 The first series
varied the aliphatic tail length, and the second series examined how the
positioning of cis- or trans-alkenes affected 20S CP stimulation. After
determining which fatty acids were the most active, they would be
converted into the phenolic amide to limit micelle formation and would
be more applicable for future cell dosing studies.
The first series contained molecules with aliphatic tails ranging in
length from eight to sixteen carbons. Molecules with tails of thirteen
carbons or less weakly stimulated the 20S CP. A significant jump in
stimulation of 20S CP activity was observed with molecules with ali-
phatic tails of fourteen and sixteen carbons, Supporting Information
Table S4. None of these were as effective as oleic acid. Three molecules,
13–15, were next synthesized and tested. These three molecules con-
tained the cis-alkene between carbons nine and ten, similar to oleic
acid. Oleic acid has 18 carbons in its aliphatic tail; these new molecules
contained 16 or 18 carbons with an additional trans-alkene as compared
to oleic acid, while molecule 15 had a total chain length of 18 carbons
with another cis-alkene between carbons 12 and 13. Molecule 14
showed the best ability to stimulate the 20S CP, which is not surprising
as its structure is the most similar to oleic acid, Table 3.
AM-404, molecule 16, and molecule 19 were then tested to de-
termine their EC50 and how much stimulation can be obtained at their
EC50 value, Fig. 2A. AM-404, not surprisingly, stimulates the 20S CP the
most at its EC50 (28 µM) to nearly 1000% over basal level. Molecules 16
and 19 have similar EC50 values to AM-404 at 35 µM and 24 µM, but
they increase 20S CP stimulation over basal level 400% and 500%,
respectively. These molecules were also tested for their toxicity in HEK-
293T cells. Not surprisingly, AM-404 is the most toxic, which is why we
wanted to synthesize derivatives that were still able to stimulate the
20S CP but would lead to potentially less off-target effects. Molecules
16 and 19 were less toxic than AM-404 at high concentrations, but this
could be due to their lower ability to stimulate the 20S CP, Fig. 2B.
More studies are required to determine if there is a correlation between
level of 20S CP stimulation and toxicity. We tested only the toxicity of
the aminophenol capped derivatives (molecules 16 and 19) and not the
unsaturated fatty acid derivatives (molecules 13 and 14) because of
their lack of solubility in the amount of DMSO that the cell assay could
tolerate before unwanted cytotoxic effects were observed.
Table 3
Fatty acids with a cis-alkene between carbons nine and ten can increase the
activity of the 20S CP.
Molecule
Structure
Stimulation
191%
13
14
15
264%
160%
Molecules 16, 19, and AM-404 were tested to determine if their
toxicity was elicited from disrupting the integrity of the cell’s mem-
brane. We used a colorimetric assay to detect the amount of lactate
dehydrogenase (LDH) that had been released into the media, indicating
3

R.A. Coleman et al.
Bioorganic&MedicinalChemistryLettersxxx(xxxx)xxx–xxx
Fig. 2. (A) EC50 curves for AM-404, 16, and 19. Their EC50 values are similar, but AM-404 still is the most effective stimulator. (B) HEK-293T cells were treated for 16
hrs with varying concentrations of the stimulators. Toxicity was not observed until 50 µM.
a damaged membrane. After dosing for 24 hrs with our molecules of
interest, the results indicate that cytotoxicity is not related to disruption
of the cell’s membrane, Supporting Information Fig. S1. AM-404 has
previously been reported that it can affect NF-kB activation, COX-2
expression, and NFAT signaling.18,19 We are currently evaluating mo-
lecules 16 and 19 to determine if they also affect these cellular targets.
This study has demonstrated that aliphatic stimulators of the 20S CP
work the best when there is a cis-alkene present and that molecules with
long saturated chains are generally not able to stimulate the activity of
the 20S CP. While AM-404 still remains the most active stimulator, it
may be too potent and lead to significant off-target effects. A molecule
such as 16 or 19, which has half of the activity of AM-404 in the bio-
chemical assay, may still provide enough stimulation to help the 20S CP
degrade accumulated toxic proteins but lead to less cytotoxicity. Studies
to understand how much stimulation is required to degrade a protein
such as α-synuclein are currently ongoing. We are also working towards
generating structures of the interaction of AM-404 and the 20S CP using
a variety of biophysical techniques in order to rationally design better
molecules.
doi.org/10.1016/j.bmcl.2018.12.030.
References
1. Lecker SH. Protein degradation by the ubiquitin-proteasome pathway in normal and
disease states. J Am Soc Nephrol. 2006;17:1807–1819.
2. Opoku-Nsiah KA, Gestwicki JE. Aim for the core: suitability of the ubiquitin-in-
dependent 20S proteasome as a drug target in neurodegeneration. Transl Res.
2018;198:48–57.
3. Huang X, Luan B, Wu J, Shi Y. An atomic structure of the human 26S proteasome. Nat
Struct Mol Biol. 2016;23:778–785.
4. Coleman R, Trader D. All about the core: a therapeutic strategy to prevent protein
accumulation. ACS Pharmacol Transl Sci. 2018;1:140–142.
5. Reeg S, Grune T. Protein oxidation in aging: does it play a role in aging progression?
Antioxid Redox Signal. 2015;23:239–255.
6. Husom AD, Peters EA, Kolling EA, Fugere NA, Thompson LV, Ferrington DA. Altered
proteasome function and subunit composition in aged muscle. Arch Biochem Biophys.
2004;421:67–76.
7. McNaught KS, Jenner P. Proteasomal function is impaired in substantia nigra in
Parkinson’s disease. Neurosci Lett. 2001;297:191–194.
8. Huang Q, Figueiredo-Pereira ME. Ubiquitin/proteasome pathway impairment in
neurodegeneration: therapeutic implications. Apoptosis. 2010;15:1292–1311.
9. Coleman R, Trader D. Development and application of a sensitive peptide reporter to
discover 20S proteasome stimulators. ACS Comb Sci. 2018;20:269–276.
10. Jones CL, Njomen E, Sjögren B, Dexheimer TS, Tepe JJ. Small molecule enhancement
of 20S proteasome activity targets intrinsically disordered proteins. ACS Chem Biol.
2017;12:2240–2247.
Author contributions
11. Witkowska J, Giżyńska M, Grudnik P, et al. Crystal structure of a low molecular
weight activator Blm-pep with yeast 20S proteasome – insights into the enzyme
activation mechanism. Sci Rep. 2017;7.
RAC tested all compounds for biological activity and helped to write
the manuscript. CSM was responsible for synthesizing the oleic acid
derivatives, acquiring NMR data for these compounds, analyzing all
NMRs with the exception of those synthesized by YZ, creating the TOC
figure, and helped to write the manuscript. YZ was responsible for
synthesizing the phenol amide derivatives from the unsaturated car-
boxylic acids. AB synthesized the compounds in Tables 1 and 2. YZ was
supervised by TRN and both helped to write this manuscript. DJT su-
pervised RAC, CSM, and AB along with writing this manuscript.
12. Trader D, Simanski S, Kodadek T. Establishment of a suite of assays that support the
discovery of proteasome agonists. Biochim Biophys Acta. 2017;1861:892–899.
13. Shibatani T, Ward WF. Sodium dodecyl sulfate (SDS) activation of the 20S protea-
some in rat liver. Arch Biochem Biophys. 1995;321:160–166.
14. Costa B, Siniscalco D, Trovato AE, et al. AM404, an inhibitor of anandamide uptake,
prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat
model of neuropathic pain: AM404 relieves neuropathic pain. Br J Pharmacol.
2009;148:1022–1032.
15. Saliba SW, Marcotegui AR, Fortwängler E, et al. AM404, paracetamol metabolite,
prevents prostaglandin synthesis in activated microglia by inhibiting COX activity. J
Neuroinflammation. 2017;14.
Acknowledgments
16. Miyashita K, Nara E, Ota T. Oxidative stability of polyunsaturated fatty acids in an
aqueous solution. Biosci Biotechnol Biochem. 1993;57:1638–1640.
17. Zhao Y, Chen Y, Newhouse TR. Allyl-palladium-catalyzed α, β-dehydrogenation of
carboxylic acids via enediolates. Angew Chem Int Ed. 2017;56:13122–13125.
18. Caballero FJ, Soler-Torronteras R, Lara-Chica M, et al. AM404 inhibits NFAT and NF-
κB signaling pathways and impairs migration and invasiveness of neuroblastoma
cells. Eur J Pharmacol. 2015;746:221–232.
The work by the Trader laboratory was supported through a start-up
package from Purdue University School of Pharmacy, the Purdue
University Center for Cancer Research NIH grant P30 CA023168 and a
grant from the Ralph W. and Grace M. Showalter Research Trust. The
work by the Newhouse laboratory was supported by a NSF-CAREER
Grant (CHE-1653793).
19. Högestätt ED, Jönsson BAG, Ermund A, et al. Conversion of acetaminophen to the
bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent
arachidonic acid conjugation in the nervous system. J Biol Chem.
2005;280:31405–31412.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
4